Articles tagged with Myocardial Infarction
A new analysis of over 10,000 patients with unstable angina or non-ST-segment elevation myocardial infarction found that the newer low molecular weight heparin enoxaparin improved outcomes compared to unfractionated heparin. The study also showed a reduced risk of death or non-fatal heart attack in patients treated with LMWH.
A joint effort by Michigan hospitals led to improved delivery of proven medications, reduced use of potentially toxic dye, and lower risk-adjusted rate of in-hospital death. The project also showed reductions in unnecessary use of a blood thinner after the procedure.
A Phase II clinical study of TP10 found that the complement inhibitor significantly reduced heart attacks and death in male patients undergoing open heart surgery. The study showed a significant decrease in composite endpoints for death, myocardial infarction, and prolonged intubation in males treated with TP10.
Researchers develop new approach to treating extreme artery blockages using G-CSF treatment. Insurance disparities are found in diabetic minorities with a lack of coverage driving disparities in preventive care.
Researchers discovered that a growth factor, granulocyte colony stimulating factor (G-CSF), can increase the number of stem cells in the heart, which may help repair damaged heart tissue. After six weeks, patients showed significant improvements in heart function and metabolic recovery.
A new study found that patients living in neighborhoods with high poverty rates had a 30% higher death rate after a heart attack. Researchers analyzed data from the Worcester Heart Attack Study, which included 2,539 confirmed cases of heart attack collected between 1995 and 1999.
Researchers have successfully treated heart attack patients with stem cells harvested from their own bone marrow, resulting in improved cardiac function and increased blood flow to the damaged area. This breakthrough therapy could potentially lead to a new treatment for heart attacks.
A new study found valsartan therapy to be as effective as ACE inhibitors in reducing cardiovascular risk after a heart attack. Combining the two medications showed no additional benefit, but was associated with more adverse events.
Researchers found that exposure to fine particles of less than 10 micrometers increased the risk of heart attacks in smokers, even at levels lower than current national standards. Air pollution levels in Dijon remained under four on the ATMO index 86 percent of the time.
The Get With The Guidelines Coronary Artery Disease (GWTG-CADSM) program improved treatment quality for heart attack patients by increasing the use of aspirin and beta-blockers. Gender gaps in treatment were also reduced, with more women receiving life-saving therapies.
Women with heart attacks tend to have milder blockages in their arteries but are less likely to receive aggressive drug therapy or undergo procedures like angioplasty. This disparity may be due to the disease itself, rather than bias against women's treatment.
Researchers found that unusual fatigue was the most common early symptom reported by women before their heart attacks, with 70% of cases. The study's lead author emphasizes the importance of educating women about new symptoms and seeking medical care to determine their cause, especially those with known cardiovascular risks.
Patients with a history of coronary disease are at high risk of experiencing acute coronary events, including unstable angina and heart attacks, after aspirin withdrawal. Aspirin therapy is essential in reducing the risk of developing acute blockage in coronary arteries.
Researchers found that EPO reduced programmed cell death in heart cells, leading to smaller infarcts and increased heart function. The study suggests that EPO may offer novel protection against ischemic events in patients with acute coronary syndrome.
Heme flooding can shut down cell membrane channels, killing neurons and constricting blood vessels. Researchers found a chemical called NS1619 restores channel function and may lead to a new treatment.
Mt. Sinai researchers found that aspirin significantly reduces the risk of a first heart attack in apparently healthy individuals by one-third. The study's findings support treatment guidelines issued by the American Heart Association and U.S. Preventive Services Task Force, recommending aspirin use for those at high risk.
Researchers found that oxygen-sensitive genes in cardiac fibroblasts transform into myofibroblasts, critical for wound healing after a heart attack. The newly formed myofibroblasts help replace damaged tissue.
Researchers discovered that 'hot pepper' receptors on the heart trigger symptoms of heart attack and may lead to new treatments for angina pectoris. The study found that these receptors cause blood vessels to constrict and increase blood pressure, leading to chest pain.
The Canadian Institutes of Health Research and National Heart, Lung and Blood Institute have launched three research programs to address heart attack resuscitation, cellular imaging, and thrombotic disorders. The programs aim to improve cardiovascular disease treatment outcomes, particularly in developing countries.
A recent study of 118 heart patients found that while they made significant progress reducing fat intake, many failed to adopt a diet rich in fruits and vegetables. After two years, only 23% were meeting the recommended daily intake, highlighting the need for targeted nutrition education.
A study published in Psychosomatic Medicine found that women have higher levels of anxiety after a heart attack compared to men. The researchers also discovered that both men and women under age 60 reported higher anxiety levels, while older individuals experienced lower anxiety due to their expectation of illness.
A large study found that estrogen replacement therapy prolongs the QT interval, increasing risk for arrhythmia and heart problems. Women who used hormone therapy had a 50% higher odds of QT prolongation compared to those who never used hormones.
A blood test could identify biological markers that indicate the onset of a heart attack or stroke, leading to life-saving intervention. Researchers are developing a diagnostic tool using 'sick cells' markers, which may be available in three to five years.
Researchers at Cedars-Sinai Medical Center have triggered a protective immune response in mice, significantly reducing atherosclerosis by 60% through immunization. The study aims to develop a vaccine to interrupt the inflammatory process and prevent heart attacks and strokes.
A study of over 5,980 women aged 67 or older found that breast cancer survivors had 34% fewer hospitalizations for heart attacks than non-survivors. The protective effect increased with higher cardiac risk factors, suggesting that female hormone levels may play a role in preventing heart disease.
A recent study found that treating heart disease patients for depression and low social support does not improve their overall survival rate. However, the treatment did lead to significant improvements in quality of life, with depressed patients experiencing a 57% reduction in depression symptoms after six months.
Researchers found that treatment helps reduce depression and feelings of isolation in patients, but it does not change the risk of future heart attacks or death. Half of the study participants received psychological counseling and behavioral therapy, while the other half got standard medical care.
A new study published in the Journal of the American Medical Association found that treating depression and social isolation in heart attack patients does not improve survival rates, but significantly improves quality of life. The ENRICHD trial followed 2,481 heart attack patients with depression or low social support for 29 months.
A new blood test can detect heart attacks in just five minutes with a 99% accuracy rate, improving diagnosis and treatment outcomes. The test identifies two proteins associated with the earliest stages of a heart attack, reducing unnecessary hospital stays.
A UK multi-centre randomised trial found that statins reduce the risk of heart attacks, strokes or revascularisation operations by about a third in diabetic patients, irrespective of their cholesterol levels. This could prevent at least 10,000 heart attacks, strokes and revascularisation operations each year worldwide.
A new study found that current low-dose oral contraceptives significantly increase plasma concentrations of C-reactive protein (CRP), an inflammatory biomarker associated with cardiovascular disease. CRP levels were two times higher among OC users than non-users, regardless of diet assignment or phase of the menstrual cycle.
Researchers have found a potential genetic link between variations in the beta-2 receptor gene and a reduced risk of heart attack and death from coronary disease. The study, published by the American Heart Association, suggests that individuals with certain forms of the gene may be more resilient to cardiovascular disease.
The study, published online in the Lancet, found that atorvastatin significantly reduces the likelihood of heart attacks and strokes in people with high blood pressure. The results are great news for those suffering from high blood pressure, as the drug also lowers cholesterol levels.
Dr. Shah will receive the ACC's Gifted Teacher Award for his teaching, and the Vulnerable Plaque Lifetime Achievement Award from AEHA for his pioneering research on preventing and reversing plaque buildup. These awards recognize his contributions to advancing cardiovascular care.
A new international study found that the life-saving effect of eplerenone began soon after patients started taking the drug following their heart attacks. The study showed a significant reduction in deaths and hospitalizations among heart attack patients with heart failure, especially when combined with other heart medications.
A new study found that calcification in heart valves is independently associated with an increased risk of heart attack and death. After adjusting for known risk factors, the researchers found that individuals with MAC were 50% more likely to develop cardiovascular disease and 60% more likely to die from cardiovascular causes.
Research suggests that employed African-American women have a 33% lower risk of coronary events compared to their homemaking counterparts. The study found no significant difference in heart disease rates among white women who worked outside the home and those who were homemakers.
Researchers analyzed VA records of 4,340 patients who received heart attack care between 1994-1995. Patients with mental illness had a slightly lower rate of diagnostic angiography, but no significant difference in survival rates for 90 days after the heart attack.
Researchers report improved left-ventricular and overall heart function in a 72-year-old man after receiving undifferentiated stem cells. The grafted scar showed the presence of well-developed skeletal myotubes with preserved contractile structure, indicating long-term viability and functional potential.
Researchers found that MRI accurately diagnosed acute coronary syndrome in 84% of patients, outperforming traditional tests like EKG and blood enzyme test. MRI detected all patients' heart attacks, even those with normal EKGs, and identified more patients with unstable angina.
A new study published in the New England Journal of Medicine found that frequent light-to-moderate drinking reduces heart disease risk in men. Men who consumed alcohol three or four days a week had approximately 2/3 the risk of heart attack compared to those who drank less than once a week.
A study found that near-daily intake of alcohol is associated with the lowest risk of heart attacks in men. Regular consumption at least three to four days per week was linked to a reduced risk of coronary heart disease.
A new study published in The Lancet found that balloon angioplasty was more effective than thrombolytic therapy in reducing death, nonfatal heart attacks, and strokes in patients with ST-segment elevation myocardial infarction. Long-term data showed that angioplasty's benefits were sustained for six to 18 months.
Experimental evidence suggests that stem cell implantation can trigger angiogenesis in damaged heart tissue, leading to improved blood flow and potentially safe treatment outcomes. However, further controlled studies are needed to fully understand the role of cell transplantation in myocardial regeneration.
A new study found that moderate beer drinking is associated with lower heart attack risk, as shown by decreased cholesterol levels, increased antioxidants, and reduced fibrinogen levels. The study also discovered structural changes in fibrinogen caused by beer consumption, which may serve as a new diagnostic indicator for heart attack ...
A new study suggests that high levels of inflammatory protein CRP are strongly associated with an increased risk of ischemic heart disease. The research found that patients taking beta blockers and statins had less inflammation, indicating that treating inflammation may play a crucial role in preventing heart disease.
Researchers found that mercury in fish counteracts the benefits of omega-3 fatty acids, increasing the risk of heart attack. Consuming low-mercury fish like salmon can help reduce cardiovascular risk.
Patients who received outpatient cardiology care had lower two-year mortality rates compared to those without. Concurrent care by cardiologists and primary care physicians may improve outcomes.
A sub-analysis of the ASSENT-3 trial data found that anti-coagulation drugs have different effects in patients with diabetes after a heart attack. Enoxaparin was recommended for acute heart attack patients with diabetes due to its lower risk of death and refractory chest pain compared to abciximab.
A study of ICD patients found a significant increase in dangerous irregular heartbeats after a terrorist attack, highlighting the impact of stress on the heart. The rate of ICD discharges remained elevated for a month following the attack.
A meta-analysis of randomized trials confirms that aspirin significantly reduces first heart attack risk and combined cardiovascular events. The study supports recent guidelines recommending aspirin therapy for individuals with a 10% or greater 10-year coronary event risk.
A Phase II trial found that pexelizumab reduced the death rate in patients who received angioplasty, but not infarct size. The researchers suggest a new mechanism of action and plan further studies to explore its effects on patient outcomes.
A new study by the American Heart Association found that death rates are significantly lower in hospitals that follow established guidelines for treating heart attacks. The study examined adherence to clinical practice guidelines at 1,085 US hospitals and found that leading hospitals had a 50% higher rate of beta-blocker use and a 30% ...
A recent study at Duke University Medical Center found hospitals that adhere to established treatment guidelines for heart attacks have lower mortality rates. The researchers compared over 250,000 patients and found leading hospitals reported significantly better outcomes.
A randomized trial of 1000 patients with a history of CAD found that a Mediterranean-style diet rich in alpha-linolenic acid significantly reduced cardiac events and mortality. The study demonstrated improved metabolic profiles without increased non-cardiac deaths.
A new NHLBI study has found improved heart failure survival rates, with deaths decreasing by 12% per decade for both men and women. The study, which analyzed data from 10,317 participants over 50 years, also revealed a significant drop in new cases of heart failure among women during the same period.
A comprehensive periodontal examination can save lives by detecting undiagnosed protein S deficiency, a condition that causes thrombotic disorders and increases the risk of strokes and heart attacks. Early diagnosis is key to successful treatment outcomes and improved survival rates for patients with this condition.
Researchers found that beta blockers significantly reduced overall death rates by 16-34% in two years, regardless of inducible tachycardia presence. However, the drugs did not reduce arrhythmic death or cardiac arrest, but showed a trend towards fewer events with combined antiarrhythmic and beta blocker therapy.
A new study published by the American Heart Association found that MRI stress tests can predict fatal and nonfatal heart attacks in patients with certain conditions. The study used MRI stress tests on 279 men and women referred for further testing after initial ultrasound screenings were inconclusive.
Researchers found that combining calcium scores and CRP levels can gauge the presence, amount, and stability of artery-clogging plaque. Elevated CRP levels were linked to increased risk of coronary events, while combined tests showed a six-fold difference in heart attack risk between high-risk and low-risk individuals.